News | April 14, 2011

Minimally Invasive Procedures Offer Help for Varicose Veins

April 14, 2011 – Varicose veins are more than just a cosmetic consideration—they can cause pain and discomfort. Treating enlarged leg veins can relieve these problems and prevent complications in the long run, explains Harvard Women’s Health Watch in its April 2011 issue.

Many women try self-help techniques for varicose veins without much success. Minimally invasive procedures, including injections, laser treatments and radiofrequency energy can help. Determining the best approach involves taking into account the size, type and location of varicose veins, notes Harvard Women’s Health Watch. Here are some of the approaches:

Sclerotherapy: A chemical irritant is injected into the vein, making it stick together and seal shut. It is slightly painful and may cause temporary swelling and bruising. Each vein typically must be injected one to three times. No anesthesia is required. Bandages and compression stockings are necessary for a week or two afterward.

Surface therapy (laser): Lasers emit a specific wavelength of light that heats and damages the vein without injuring nearby tissue. This treatment causes a strong pinching sensation. Numbing creams can lessen the sting. Other temporary side effects include bruising, itching, or swelling, and some women notice changes in skin color in the treated area. Compression stockings are needed for several days afterward.

Internal therapy (laser or radiofrequency): These methods are used to treat deeper varicose veins. The troublesome vein is located with ultrasound, and a small catheter is inserted into the vein. The catheter emits either laser or radiofrequency energy, which shrinks and seals the vein. Swelling and pain can occur, and women who have been treated should wear compression stockings for at least two weeks.

Read the full-length article: “Minimally invasive treatments for bothersome leg veins”:

Related Content

Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Overlay Init